Koala retroviruses: Characterization and impact on the life of koalas

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Denner, Joachim ^a   Young, Paul R ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Gammaretroviruses; Immunodeficiency; Koala retrovirus; Lymphoma

Indexed keywords

2',3' DIDEOXYGUANOSINE TRIPHOSPHATE; 2',3' DIDEOXYTHYMIDINE TRIPHOSPHATE; ANTIRETROVIRUS AGENT; CYTOKINE; FELINE LEUKEMIA VIRUS VACCINE; KOALA RETROVIRUS VACCINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE; ZIDOVUDINE;

ANTIVIRAL SUSCEPTIBILITY; CHLAMYDIASIS; FELINE LEUKEMIA; GAMMARETROVIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFECTION PREVENTION; KOALA; KOALA RETROVIRUS; KOALA RETROVIRUS A; KOALA RETROVIRUS B; KOALA RETROVIRUS J; LEUKEMIA; LYMPHOMA; NONHUMAN; OPPORTUNISTIC INFECTION; PROTEIN EXPRESSION; RETROVIRUS; REVIEW; VACCINATION; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS PARTICLE;

ANIMALIA; FELINE LEUKEMIA VIRUS; GAMMARETROVIRUS; GIBBON APE LEUKEMIA VIRUS; PHASCOLARCTIDAE; PORCINE ENDOGENOUS RETROVIRUS; RODENTIA;

ANIMALS; GAMMARETROVIRUS; INCIDENCE; PHASCOLARCTIDAE; RETROVIRIDAE INFECTIONS;

EID: 84886071778     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-108     Document Type: Review

References (73)

1. Booth RJ, Blanshard WH. Diseases of koalas. Zoo and wild animal medicine 1999, 321-333. Philadelphia: W.B. Saunders, Miller ME, Miller RE.
2. Moloney JB. The rodent leukemias: virus-induced murine leukemias. Annu Rev Med 1964, 15:383-392. 10.1146/annurev.me.15.020164.002123, 14133854.
3. Rosenberg N, Jolicoeur P. Retroviral pathogenesis. Retroviruses 1997, Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, Coffin JM, Hughes SH, Varmus HE.
4. Hardy WD. Feline retroviruses. Advances in viral oncology 1985, 1-34. New York: Raven, Klein G, vol. 5.
5. Hardy WD. Feline oncoretroviruses. The retroviridae 1993, 109-180. New York: Plenum Press, Levy JA, vol. 2.
6. Gallo RC, Gallagher RE, Wong-Staal F, Aoki T, Markham PD, Schetters H, Ruscetti F, Valerio M, Walling MJ, O'Keeffe RT, Saxinger WC, Smith RG, Gillespie DH, Reitz MS. Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia. Virol 1978, 84(2):359-373.
7. Kannian P, Green PL. Human T lymphotropic virus type 1 (HTLV-1): molecular biology and oncogenesis. Viruses 2010, 2(9):2037-2077. 10.3390/v2092037, 3185741, 21994719.
8. Hanger JJ, Bromham LD, McKee JJ, O'Brien TM, Robinson WF. The nucleotide sequence of koala (phascolarctos cinereus) retrovirus: a novel type C endogenous virus related to gibbon ape leukemia virus. J Virol 2000, 74:4264-4272. 10.1128/JVI.74.9.4264-4272.2000, 111943, 10756041.
9. Xu W, Stadler CK, Gorman K, Jensen N, Kim D, Zheng H, Tang S, Switzer WM, Pye GW, Eiden MV. An exogenous retrovirus isolated from koalas with malignant neoplasias in a US zoo. Proc Natl Acad Sci U S A 2013, 110(28):11547-11552. 10.1073/pnas.1304704110, 23798387.
10. Shojima T, Yoshikawa R, Hoshino S, Shimode S, Nakagawa S, Ohata T, Nakaoka R, Miyazawa T. Identification of a novel subgroup of koala retrovirus from Koalas in Japanese zoos. J Virol 2013, Epub ahead of print.
11. Martin J, Herniou E, Cook J, O'Neill RW, Tristem M. Interclass transmission and phyletic host tracking in murine leukemia virus-related retroviruses. J Virol 1999, 73:2442-2449. 104491, 9971829.
12. Lieber MM. Isolation from the Asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci USA 1975, 72:2315-2319. 10.1073/pnas.72.6.2315, 432748, 49058.
13. Cui J, Tachedjian G, Tachedjian M, Holmes EC, Zhang S, Wang LF. Identification of diverse groups of endogenous gammaretroviruses in mega- and microbats. J Gen Virol 2012, 93(Pt 9):2037-2045.
14. Cui J, Tachedjian M, Wang L, Tachedjian G, Wang LF, Zhang S. Discovery of retroviral homologs in bats: implications for the origin of mammalian gammaretroviruses. J Virol 2012, 86(8):4288-4293. 10.1128/JVI.06624-11, 3318619, 22318134.
15. Gao F. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994, 68:7433-7447. 237186, 7933127.
16. Gao F. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999, 397:436-441. 10.1038/17130, 9989410.
17. Canfield PJ, Sabine JM, Love DN. Virus particles associated with leukaemia in a koala. Aust Vet J 1988, 65(10):327-328. 10.1111/j.1751-0813.1988.tb14518.x, 3196252.
18. Miyazawa T, Shojima T, Yoshikawa R, Ohata T. Isolation of koala retroviruses from koalas in Japan. J Vet Med Sci 2011, 73(1):65-70. 10.1292/jvms.10-0250, 20805639.
19. Shojima T, Hoshino S, Abe M, Yasuda J, Shogen H, Kobayashi T, Miyazawa T. Construction and characterization of an infectious molecular clone of koala retrovirus. J Virol 2013, 7(9):5081-5088.
20. Fiebig U, Hartmann MG, Bannert N, Kurth R, Denner J. Transspecies transmission of the endogenous koala retrovirus. J Virol 2006, 80(11):5651-5654. 10.1128/JVI.02597-05, 1472152, 16699047.
21. Worley M, Rideout B, Shima A, Janssen D. Opportunistic infections, cancer and hematologic disorders associated with retrovirus infection in the koala (Phascolarctos cinereus). Proc Assoc Zoo Vet 1993, 33:181-182.
22. Ávila-Arcos MC, Ho SY, Ishida Y, Nikolaidis N, Tsangaras K, Hönig K, Medina R, Rasmussen M, Fordyce SL, Calvignac-Spencer S, Willerslev E, Gilbert MT, Helgen KM, Roca AL, Greenwood AD. One hundred twenty years of koala retrovirus evolution determined from museum skins. Mol Biol Evol 2013, 30(2):299-304. 10.1093/molbev/mss223, 3548305, 22983950.
23. Tarlinton RE, Meers J, Young PR. Retroviral invasion of the koala genome. Nature 2006, 442(7098):79-81. 10.1038/nature04841, 16823453.
24. Simmons GS, Young PR, Hanger JJ, Jones K, Clarke D, McKee JJ, Meers J. Prevalence of koala retrovirus in geographically diverse populations in Australia. Aust Vet J 2012, 90(10):404-409. 10.1111/j.1751-0813.2012.00964.x, 23004234.
25. Tarlinton R, Meers J, Young P. Biology and evolution of the endogenous koala retrovirus. Cell Mol Life Sci 2008, 65(21):3413-3421. 10.1007/s00018-008-8499-y, 18818870.
26. Denner J. Endogenous retroviruses. Retroviruses: molecular biology, genomics and pathogenesis 2010, 35-69. Hethersett, Norwich: Caister Academic Press, Kurth R, Bannert N.
27. Oliveira NM, Farrell KB, Eiden MV. In vitro characterization of a koala retrovirus. J Virol 2006, 80(6):3104-3107. 10.1128/JVI.80.6.3104-3107.2006, 1395464, 16501122.
28. Denner J, Tönjes RR. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev 2012, 25(2):318-343. 10.1128/CMR.05011-11, 3346299, 22491774.
29. Denner J, Specke V, Thiesen U, Karlas A, Kurth R. Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells. Virology 2003, 15(1):125-133. 314.
30. DesGrosseillers L, Jolicoeur P. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J Virol 1984, 52:945-952. 254618, 6092722.
31. Athas B, Choi S, Prabhu P, Lobelle-Rich L, Levy S. Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology 1995, 214:431-438. 10.1006/viro.1995.0053, 8553544.
32. Linial M. Why aren't foamy viruses pathogenic?. Trends Microbiol 2000, 8(6):284-289. 10.1016/S0966-842X(00)01763-7, 10838587.
33. German AC, Harbour DA, Helps CR, Gruffydd-Jones TJ. Is feline foamy virus really apathogenic?. Vet Immunol Immunopathol 2008, 123(1-2):114-118.
34. Brown AS, Girjes AA, Lavin MF, Timms P, Woolcock JB. Chlamydial disease in koalas. Aust Vet J 1987, 64:346-350. 10.1111/j.1751-0813.1987.tb06064.x, 3328978.
35. O'Dair HA, Hopper CD, Gruffydd-Jones TJ, Harbour DA, Waters L. Clinical aspects of Chlamydia psittaci infection in cats infected with feline immunodeficiency virus. Vet Rec 1994, 134:365-368. 10.1136/vr.134.15.365, 8009798.
36. Contini C. Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV associated dementia complex. J Neuroimmunol 2003, 136:172-177. 10.1016/S0165-5728(02)00469-1, 12620657.
37. Tarlinton R, Meers J, Hanger J, Young P. Real-time reverse transcriptase PCR for the endogenous koala retrovirus reveals an association between plasma viral load and neoplastic disease in koalas. J Gen Virol 2005, 86(Pt 3):783-787.
38. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997, 126(12):946-954. 10.7326/0003-4819-126-12-199706150-00003, 9182471.
39. Oostendorp RA, Meijer CJ, Scheper RJ. Immunosuppression by retroviral-envelope-related proteins, and their role in non-retroviral human disease. Crit Rev Oncol Hematol 1993, 14:189-206. 10.1016/1040-8428(93)90009-S, 8397847.
40. Denner J. Immunosuppression by retroviruses: implications for xenotransplantation. Ann NY Acad Sci 1998, 862:75-86. 10.1111/j.1749-6632.1998.tb09119.x, 9928208.
41. Mangeney M, de Parseval N, Thomas G, Heidmann T. The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties. J Gen Virol 2001, 82:2515-2518.
42. Denner J. Immunosuppression by oncogenic retroviridae. Immune modulation by infectious agents 1987, 114-201. Jena: Fischer Verlag, Zschiesche W.
43. Hofmann-Lehmann R, Holznagel E, Ossent P, Lutz H. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets. Clin Diagn Lab Immunol 1997, 4:33-42. 170472, 9008278.
44. Speth C, Joebstl B, Barcova M, Dierich MP. HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones. AIDS 2000, 14(6):629-636. 10.1097/00002030-200004140-00001, 10807185.
45. Barcova M, Kacani L, Speth C, Dierich MP. gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production. J Infect Dis 1998, 177(4):905-913. 10.1086/515230, 9534962.
46. Denner J, Eschricht M, Lauck M, Semaan M, Schlaermann P, Ryu H, Akyüz L. Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1. PLoS One 2013, 8(1):e55199. 10.1371/journal.pone.0055199, 3559347, 23383108.
47. Morozov VA, Morozov AV, Semaan M, Denner J. Single mutations in the transmembrane envelope protein abrogate the immunosuppressive property of HIV-1. Retrovirol 2012, 9:67.
48. Morozov VA, Dao Thi VL, Denner J. The transmembrane protein of the human endogenous retrovirus - K (HERV-K) modulates cytokine release and gene expression. Plos one 2013, 8(8):e70399. 10.1371/journal.pone.0070399, 3737193, 23950929.
49. Tacke SJ, Kurth R, Denner J. Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation?. Virology 2000, 268(1):87-93. 10.1006/viro.1999.0149, 10683330.
50. Cianciolo G, Copeland T, Oroszlan S, Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985, 230:453-455. 10.1126/science.2996136, 2996136.
51. Denner J, Norley S, Kurth R. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. Aids 1994, 8:1063-1072. 10.1097/00002030-199408000-00005, 7986401.
52. Denner J, Persin C, Vogel T, Haustein D, Norley S, Kurth R. The immunosuppressive peptide of HIV-1 inhibits T and B lymphocyte stimulation. J Acquir Immune Defic Syndr Hum Retrov 1996, 12(5):442-450.
53. Ruegg C, Monell C, Strand M. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J Virol 1989, 63:3257-3260. 250896, 2526228.
54. Mangeney M, Heidmann T. Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci U S A 1998, 8(25):14920-14925. 95.
55. Blaise S, Mangeney M, Heidmann T. The envelope of Mason-Pfizer monkey virus has immunosuppressive properties. J Gen Virol 2001, 82(Pt 7):1597-1600.
56. Schlecht-Louf G, Renard M, Mangeney M, Letzelter C, Richaud A, Ducos B, Bouallaga I, Heidmann T. Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses. Proc Natl Acad Sci U S A 2010, 107(8):3782-3787. 10.1073/pnas.0913122107, 2840525, 20142478.
57. Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, Richaud A, Ducos B, Heidmann T. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci U S A 2007, 104(51):20534-20539. 10.1073/pnas.0707873105, 2154466, 18077339.
58. Wilhelm M, Fishman JA, Pontikis R, Aubertin AM, Wilhelm FX. Susceptibility of recombinant porcine endogenous retrovirus reverse transcriptase to nucleoside and non-nucleoside inhibitors. Cell Mol Life Sci 2002, 59(12):2184-2190. 10.1007/s000180200017, 12568344.
59. Stephan O, Schwendemann J, Specke V, Tacke SJ, Boller K, Denner J. Porcine endogenous retroviruses (PERVs): generation of specific antibodies, development of an immunoperoxidase assay (IPA) and inhibition by AZT. Xenotransplant 2001, 8(4):310-316.
60. Langhammer S, Hübner J, Jarrett O, Kurth R, Denner J. Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: absence of antigenemia following challenge. Antiviral Res 2011, 89(1):119-123. 10.1016/j.antiviral.2010.11.011, 21108970.
61. Fink MA, Rauscher FJ. Immune reactions to a murine leukemia virus I. Induction of immunity to infection with virus in the natural host. J Natl Cancer Inst 1964, 32:1075-1082.
62. Hunsmann G. Subunit vaccines against exogenous retroviruses: overview and perspectives. Cancer Res 1985, 45:4691-4693.
63. Fischinger PJ, Schäfer W, Bolognesi DP. Neutralization of homologous and heterologous oncornaviruses by Antisera against the p15(E) and gp71 polypeptides of friend murine leukemia virus. Virology 1976, 71(1):169-184. 10.1016/0042-6822(76)90103-3, 58469.
64. Ruan KS, Lilly F. Approach to a retrovirus vaccine: immunization of mice against friend virus disease with a replication-defective friend murine leukemia virus. Proc Natl Acad Sci U S A 1992, 89(24):12202-12206. 10.1073/pnas.89.24.12202, 50727, 1465459.
65. Ruprecht RM, Hu Y, Liska V, Rasmussen R, Sharma P. Correlates of immune protection after vaccination with attenuated live murine leukemia virus. AIDS Res Hum Retrov 1996, 12(5):375-377.
66. Fiebig U, Stephan O, Kurth R, Denner J. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation. Virology 2003, 307(2):406-413. 10.1016/S0042-6822(02)00140-X, 12667808.
67. Kaulitz D, Fiebig U, Eschricht M, Wurzbacher C, Kurth R, Denner J. Generation of neutralising antibodies against porcine endogenous retroviruses (PERVs). Virology 2011, 411(1):78-86. 10.1016/j.virol.2010.12.032, 21237477.
68. Waechter A, Eschricht M, Denner J. Neutralization of porcine endogenous retrovirus by antibodies against the membrane-proximal external region of the transmembrane envelope protein. J Gen Virol 2013, 94(Pt 3):643-651.
69. Langhammer S, Fiebig U, Kurth R, Denner J. Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV). Vaccine 2005, 23(25):3341-3348. 10.1016/j.vaccine.2005.01.091, 15837241.
70. Langhammer S, Hübner J, Kurth R, Denner J. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E. Immunology 2006, 117(2):229-237. 10.1111/j.1365-2567.2005.02291.x, 1782217, 16423059.
71. Denner J. Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study. Hum Vaccin Immunother 2012, 9(3):462-470.
72. Langhammer S, Fiebig U, Kurth R, Denner J. Increased neutralizing antibody response after simultaneous immunization with Leucogen and the feline leukemia virus transmembrane protein. Intervirol 2011, 54(2):78-86.
73. Denner J, Mihica D, Kaulitz D, Schmidt CM. Increased titers of neutralizing antibodies after immunization with both envelope proteins of the porcine endogenous retroviruses (PERVs). Virol J 2012, 9:260. 10.1186/1743-422X-9-260, 3554530, 23126255.